Information Technology Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
WAY vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
WAY vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Information Technology Services | Medical - Healthcare Plans |
| Market Cap | $3.60B | $370.80B |
| Revenue (TTM) | $1.16B | $449.71B |
| Net Income (TTM) | $126M | $12.04B |
| Gross Margin | 65.2% | 18.8% |
| Operating Margin | 24.3% | 4.2% |
| Forward P/E | 11.4x | 22.2x |
| Total Debt | $1.50B | $78.39B |
| Cash & Equiv. | $61M | $24.36B |
WAY vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 24 | Jun 26 | Return |
|---|---|---|---|
| Waystar Holding Cor… (WAY) | 100 | 87.2 | -12.8% |
| UnitedHealth Group … (UNH) | 100 | 80.2 | -19.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WAY vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WAY is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 16.5%, EPS growth 5.7%, 3Y rev CAGR 16.0%
- Lower volatility, beta 0.84, Low D/E 38.7%, current ratio 1.41x
- 16.5% revenue growth vs UNH's 11.8%
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 16 yrs, beta 0.61, yield 2.1%
- 236.1% 10Y total return vs WAY's -9.4%
- Beta 0.61, yield 2.1%, current ratio 0.79x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.5% revenue growth vs UNH's 11.8% | |
| Value | Lower P/E (11.4x vs 22.2x) | |
| Quality / Margins | 10.9% margin vs UNH's 2.7% | |
| Stability / Safety | Beta 0.61 vs WAY's 0.84 | |
| Dividends | 2.1% yield; 16-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +31.0% vs WAY's -52.6% | |
| Efficiency (ROA) | 3.9% ROA vs WAY's 2.4%, ROIC 9.2% vs 4.2% |
WAY vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WAY vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WAY leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 388.8x WAY's $1.2B. WAY is the more profitable business, keeping 10.9% of every revenue dollar as net income compared to UNH's 2.7%. On growth, WAY holds the edge at +22.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.2B | $449.7B |
| EBITDAEarnings before interest/tax | $430M | $23.2B |
| Net IncomeAfter-tax profit | $126M | $12.0B |
| Free Cash FlowCash after capex | $294M | $19.7B |
| Gross MarginGross profit ÷ Revenue | +65.2% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +24.3% | +4.2% |
| Net MarginNet income ÷ Revenue | +10.9% | +2.7% |
| FCF MarginFCF ÷ Revenue | +25.4% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +22.4% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +37.5% | +0.7% |
Valuation Metrics
WAY leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 30.7x trailing earnings, WAY trades at a 0% valuation discount to UNH's 30.9x P/E. On an enterprise value basis, WAY's 12.4x EV/EBITDA is more attractive than UNH's 18.2x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $370.8B |
| Enterprise ValueMkt cap + debt − cash | $5.0B | $424.8B |
| Trailing P/EPrice ÷ TTM EPS | 30.74x | 30.88x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.42x | 22.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 12.39x | 18.21x |
| Price / SalesMarket cap ÷ Revenue | 3.27x | 0.83x |
| Price / BookPrice ÷ Book value/share | 0.95x | 3.66x |
| Price / FCFMarket cap ÷ FCF | 12.70x | 23.07x |
Profitability & Efficiency
UNH leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $4 for WAY. WAY carries lower financial leverage with a 0.39x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs WAY's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +3.5% | +11.5% |
| ROA (TTM)Return on assets | +2.4% | +3.9% |
| ROICReturn on invested capital | +4.2% | +9.2% |
| ROCEReturn on capital employed | +5.2% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.39x | 0.77x |
| Net DebtTotal debt minus cash | $1.4B | $54.0B |
| Cash & Equiv.Liquid assets | $61M | $24.4B |
| Total DebtShort + long-term debt | $1.5B | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 3.51x | 4.71x |
Total Returns (Dividends Reinvested)
UNH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UNH five years ago would be worth $11,165 today (with dividends reinvested), compared to $9,058 for WAY. Over the past 12 months, UNH leads with a +31.0% total return vs WAY's -52.6%. The 3-year compound annual growth rate (CAGR) favors WAY at -3.2% vs UNH's -4.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -40.2% | +22.1% |
| 1-Year ReturnPast 12 months | -52.6% | +31.0% |
| 3-Year ReturnCumulative with dividends | -9.4% | -12.0% |
| 5-Year ReturnCumulative with dividends | -9.4% | +11.7% |
| 10-Year ReturnCumulative with dividends | -9.4% | +236.1% |
| CAGR (3Y)Annualised 3-year return | -3.2% | -4.2% |
Risk & Volatility
UNH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UNH is the less volatile stock with a 0.61 beta — it tends to amplify market swings less than WAY's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 98.2% from its 52-week high vs WAY's 45.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.84x | 0.61x |
| 52-Week HighHighest price in past year | $41.47 | $415.96 |
| 52-Week LowLowest price in past year | $17.89 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +45.2% | +98.2% |
| RSI (14)Momentum oscillator 0–100 | 40.3 | 66.5 |
| Avg Volume (50D)Average daily shares traded | 2.4M | 7.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates WAY as "Buy" and UNH as "Buy". Consensus price targets imply 90.0% upside for WAY (target: $36) vs 2.4% for UNH (target: $419). UNH is the only dividend payer here at 2.13% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $35.62 | $418.50 |
| # AnalystsCovering analysts | 17 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.1% |
| Dividend StreakConsecutive years of raises | — | 16 |
| Dividend / ShareAnnual DPS | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.5% |
UNH leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). WAY leads in 2 (Income & Cash Flow, Valuation Metrics).
WAY vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is WAY or UNH a better buy right now?
For growth investors, Waystar Holding Corp.
(WAY) is the stronger pick with 16. 5% revenue growth year-over-year, versus 11. 8% for UnitedHealth Group Incorporated (UNH). Waystar Holding Corp. (WAY) offers the better valuation at 30. 7x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Waystar Holding Corp. (WAY) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WAY or UNH?
On trailing P/E, Waystar Holding Corp.
(WAY) is the cheapest at 30. 7x versus UnitedHealth Group Incorporated at 30. 9x. On forward P/E, Waystar Holding Corp. is actually cheaper at 11. 4x.
03Which is the better long-term investment — WAY or UNH?
Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of +11.
7%, compared to -9. 4% for Waystar Holding Corp. (WAY). Over 10 years, the gap is even starker: UNH returned +236. 1% versus WAY's -9. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WAY or UNH?
By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.
61β versus Waystar Holding Corp. 's 0. 84β — meaning WAY is approximately 37% more volatile than UNH relative to the S&P 500. On balance sheet safety, Waystar Holding Corp. (WAY) carries a lower debt/equity ratio of 39% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.
05Which is growing faster — WAY or UNH?
By revenue growth (latest reported year), Waystar Holding Corp.
(WAY) is pulling ahead at 16. 5% versus 11. 8% for UnitedHealth Group Incorporated (UNH). On earnings-per-share growth, the picture is similar: Waystar Holding Corp. grew EPS 569. 2% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, WAY leads at 16. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WAY or UNH?
Waystar Holding Corp.
(WAY) is the more profitable company, earning 10. 2% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 10. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WAY leads at 24. 2% versus 4. 2% for UNH. At the gross margin level — before operating expenses — WAY leads at 64. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WAY or UNH more undervalued right now?
On forward earnings alone, Waystar Holding Corp.
(WAY) trades at 11. 4x forward P/E versus 22. 2x for UnitedHealth Group Incorporated — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WAY: 90. 0% to $35. 62.
08Which pays a better dividend — WAY or UNH?
In this comparison, UNH (2.
1% yield) pays a dividend. WAY does not pay a meaningful dividend and should not be held primarily for income.
09Is WAY or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
61), 2. 1% yield, +236. 1% 10Y return). Both have compounded well over 10 years (UNH: +236. 1%, WAY: -9. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WAY and UNH?
These companies operate in different sectors (WAY (Technology) and UNH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: WAY is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while WAY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.